Five-year experience with Norplant®
1987; Elsevier BV; Volume: 36; Issue: 4 Linguagem: Inglês
10.1016/0010-7824(87)90090-4
ISSN1879-0518
AutoresBiran Affandi, S.S.I. Santoso, Djajadilaga Djajadilaga, W. Hadisaputra, F. A. Moeloek, Joedo Prihartono, F. Lubis, Ratna Suprapti Samil,
Tópico(s)Glycogen Storage Diseases and Myoclonus
ResumoAt Klinik Raden Saleh, Department of Obstetrics and Gynaecology, University of Indonesia, from 1 May until 31 August, 1981, Norplant® contraceptive implants were inserted into 437 Indonesian women. The continuation rates of Norplant® at first, second, third, fourth and fifth year were, respectively, 96%, 92%, 88%, 82% and 78%. Bleeding problems were the most common cause for removal. The cumulative five-year net pregnancy rate for Norplant®was 1.8 per 100 women. The Norplant® contraceptive system is thus seen to combine the highest acceptability as measured by its continuation rate with the highest long-term effectiveness among the available temporary contraceptive methods.
Referência(s)